| A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise KC Howard, EK Dennis, DS Watt, S Garneau-Tsodikova Chemical Society Reviews 49 (8), 2426-2480, 2020 | 109 | 2020 |
| Alkylated piperazines and piperazine-azole hybrids as antifungal agents N Thamban Chandrika, SK Shrestha, HX Ngo, OV Tsodikov, KC Howard, ... Journal of Medicinal Chemistry 61 (1), 158-173, 2018 | 93 | 2018 |
| Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen? KC Howard, OA Gonzalez, S Garneau-Tsodikova RSC Medicinal Chemistry 12 (5), 666-704, 2021 | 42 | 2021 |
| Novel fluconazole derivatives with promising antifungal activity NT Chandrika, SK Shrestha, HX Ngo, KC Howard, S Garneau-Tsodikova Bioorganic & medicinal chemistry 26 (3), 573-580, 2018 | 34 | 2018 |
| of print. AH Pang, KD Green, A Punetha, N Thamban Chandrika, KC Howard, ... Biochemistry, 2023 | 20 | 2023 |
| Second Generation of Zafirlukast Derivatives with Improved Activity against the Oral Pathogen Porphyromonas gingivalis KC Howard, OA Gonzalez, S Garneau-Tsodikova ACS Medicinal Chemistry Letters 11 (10), 1905-1912, 2020 | 9 | 2020 |
| Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic JA Gelzinis, MK Szahaj, RH Bekendam, SE Wurl, MM Pantos, ... The FASEB Journal 37 (5), e22914, 2023 | 6 | 2023 |
| Discovery and mechanistic analysis of structurally diverse inhibitors of acetyltransferase Eis among FDA-approved drugs AH Pang, KD Green, A Punetha, N Thamban Chandrika, KC Howard, ... Biochemistry 62 (3), 710-721, 2023 | 5 | 2023 |
| Selective Inhibition of the Periodontal Pathogen Porphyromonas gingivalis by Third-Generation Zafirlukast Derivatives KC Howard, S Garneau-Tsodikova Journal of Medicinal Chemistry 65 (21), 14938-14956, 2022 | 3 | 2022 |
| Development of Zafirlukast Analogues for Improved Antithrombotic Activity Through Thiol Isomerase Inhibition JA Keovilay, KC Howard, KA Taylor, S Khan, SE Wurl, MK Szahaj, T Sage, ... Arteriosclerosis, Thrombosis, and Vascular Biology, 2024 | | 2024 |
| Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic (vol 37, e022914, 2023) JA Gelzinis, MK Szahaj, RH Bekendam, SE Wurl, MM Pantos, ... FASEB JOURNAL 38 (1), 2024 | | 2024 |
| DEVELOPMENT OF ZAFIRLUKAST DERIVATIVES AGAINST PORPHYROMONAS GINGIVALIS KC Howard University of Kentucky, 2022 | | 2022 |
| Development of zafirlukast derivatives active against Porphyromonas gingivalis KC Howard | | 2022 |
| rsc. li/medchem M Jörg, KS Madden, KC Howard, OA Gonzalez, S Garneau-Tsodikova | | |